Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

323 ARTÍCULOS , VIENDO DEL 91 AL 105

Effects of ramelteon on refractory behavioral and psychological symptoms of dementia in Alzheimer disease

Asano M, Ishitobi M, Tanaka Y, Wada Y.

J Clin Psychopharmacol. 2013 Aug;33(4):579-81. doi: 10.1097/JCP.0b013e3182946702.

Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease

Rive B, Gauthier S, Costello S, Marre C, François C.

CNS Drugs. 2013 Jul;27(7):573-82. doi: 10.1007/s40263-013-0074-x.

Effects of aging and Alzheimer's disease along the longitudinal axis of the hippocampus

Gordon BA, Blazey T, Benzinger TL, Head D.

J Alzheimers Dis. 2013;37(1):41-50. doi: 10.3233/JAD-130011.

Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease

Hatz F, Benz N, Hardmeier M, Zimmermann R, Rueegg S, Schindler C, Miserez AR, Gschwandtner U, Monsch AU, Fuhr P.

Clin Neurophysiol. 2013 Nov;124(11):2146-52. doi: 10.1016/j.clinph.2013.04.339. Epub 2013 Jun 17.

The benzazole scaffold: a SWAT to combat Alzheimer's disease

Noël S, Cadet S, Gras E, Hureau C.

Chem Soc Rev. 2013 Oct 7;42(19):7747-62. doi: 10.1039/c3cs60086f. Epub 2013 Jun 24.

Understanding placebo responses in Alzheimer's disease clinical trials from the literature meta-data and CAMD database

Ito K, Corrigan B, Romero K, Anziano R, Neville J, Stephenson D, Lalonde R.

J Alzheimers Dis. 2013;37(1):173-83. doi: 10.3233/JAD-130575.

Leveraging global resources to end the Alzheimer's pandemic

Carrillo MC.

Alzheimers Dement. 2013 Jul;9(4):363-5. doi: 10.1016/j.jalz.2013.05.1768.

Current status of PET-imaging probes of β-amyloid plaques

Koo J, Byun Y.

Arch Pharm Res. 2013 Oct;36(10):1178-84. doi: 10.1007/s12272-013-0193-4. Epub 2013 Jul 1.

Personalized medicine in Alzheimer's disease and depression

Souslova T, Marple TC, Spiekerman AM, Mohammad AA.

Contemp Clin Trials. 2013 Nov;36(2):616-23. doi: 10.1016/j.cct.2013.06.012. Epub 2013 Jun 29.

Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer's disease

Andrieux K, Couvreur P.

Ann Pharm Fr. 2013 Jul;71(4):225-33. doi: 10.1016/j.pharma.2013.04.001. Epub 2013 May 28.

Using memories to understand others: the role of episodic memory in theory of mind impairment in Alzheimer disease

Moreau N, Viallet F, Champagne-Lavau M.

Ageing Res Rev. 2013 Sep;12(4):833-9. doi: 10.1016/j.arr.2013.06.005. Epub 2013 Jul 6.

The body-mind connection in aging and dementia

Larson EB.

J Am Geriatr Soc. 2013 Jul;61(7):1210-1. doi: 10.1111/jgs.12257.

Normal pressure hydrocephalus mimicking Alzheimer's disease: such an infrequent case?

Olazarán J, Martínez MD, Rábano A.

Clin Neuropathol. 2013 Nov-Dec;32(6):502-7. doi: 10.5414/NP300614.

Caregiver outcomes of partners in dementia care: effect of a care coordination program for veterans with dementia and their family members and friends

Bass DM, Judge KS, Snow AL, Wilson NL, Morgan R, Looman WJ, McCarthy CA, Maslow K, Moye JA, Randazzo R, Garcia-Maldonado M, Elbein R, Odenheimer G, Kunik ME.

J Am Geriatr Soc. 2013 Aug;61(8):1377-86. doi: 10.1111/jgs.12362. Epub 2013 Jul 19.

Interprofessional education in community-based Alzheimer's disease diagnosis and treatment

McCaffrey R, Tappen RM, Lichtstein DM, Friedland M.

J Interprof Care. 2013 Nov;27(6):534-6. doi: 10.3109/13561820.2013.817384. Epub 2013 Jul 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias